MASSACHUSETTS FINANCIAL SERVICES CO /MA/
Position in NBIX — Neurocrine Biosciences Inc
CIK 912938
Boston, MA
Position in NBIX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$13,431,287
-$4,487,656 QoQ
Shares Held
101,953
-19.3% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.62485655154826.ToString("F0")%
Shared 1.3751434484517375.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $189,500,319 across 12 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
435,397 | $51,468,277 | |
| 2 | COLL |
Collegium Pharmaceutical, Inc
|
1,365,932 | $45,171,370 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
598,026 | $35,445,000 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
438,002 | $21,089,795 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
101,953 | $13,431,287 | |
| 6 | HLN |
Haleon plc
|
795,403 | $7,961,983 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
433,385 | $6,002,382 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
142,029 | $4,329,043 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,431,287 | 101,953 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $17,918,943 | 126,341 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $19,197,806 | 136,756 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $22,656,753 | 180,259 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $16,663,106 | 150,661 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $20,520,181 | 150,331 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $18,787,081 | 163,054 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $21,474,454 | 155,985 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $20,946,324 | 151,873 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $23,160,377 | 175,777 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $19,789,875 | 175,910 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $16,592,933 | 175,959 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $17,031,682 | 168,264 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $21,620,431 | 181,015 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $19,164,638 | 180,441 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $21,010,351 | 215,535 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $20,353,031 | 217,099 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $17,982,708 | 211,139 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $17,406,993 | 181,493 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $13,948,680 | 143,328 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $13,979,395 | 143,747 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $14,101,452 | 147,120 | Shares | Sole | 2021-05-12 | |
| 2020-09-30 | $10,898,293 | 113,335 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $14,161,394 | 116,077 | Shares | Sole | 2020-11-20 | |
| 2020-03-31 | $11,189,357 | 129,282 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||